Navigation Links
Boehringer Ingelheim Unveils Diabetes Pipeline
Date:6/6/2009

eline to week 12.(1) Out of the 333 randomized patients, 268 patients received double-blind treatment with linagliptin (1 mg, n=65; 5 mg, n=66; 10 mg, n=66) or placebo.(1) An open-label arm with 65 patients on glimepiride was added for descriptive control.(1)

Additional results from the study

The addition of linagliptin to metformin treatment for 12 weeks resulted in clinically relevant and statistically significant reductions in HbA1c and fasting blood sugar or fasting plasma glucose (FPG) levels (p-values of less than 0.05%):(1)

  • Statistically significant reductions in mean HbA1c levels with linagliptin 5 mg and 10 mg compared with metformin alone (both p<0.001) were observed from week four though week 12.(1)
  • In addition, all linagliptin doses showed significant reductions in FPG levels compared with metformin alone (placebo-corrected mean changes from baseline; -19.2 mg/dL for 1 mg, -34.7 mg/dL for 5 mg, and -29.0 mg/dL for 10 mg).(1)
  • In the open-label comparator arm, the placebo-corrected mean change from baseline in HbA1c was -0.90 percent.(1)
  • More than 85% of the patients receiving the 5mg and 10mg doses of linagliptin demonstrated greater that or equal to 80% DPP-4 inhibition at trough at week 12(1)
  • HbA1c reductions of at least 0.5 percent were achieved in 44 percent to 53 percent of patients on linagliptin, but only in 13 percent of the patients receiving metformin alone.(1)

About type 2 diabetes

There are approximately 23.6(5) million Americans and 246 million people worldwide(6) with diabetes. Type 2 diabetes is the most common type of diabetes accounting for more than 90% of all diabetes cases in the developed world.(7) Every ten seconds two people develop diabetes and one person dies from diabetes-related causes around the world.(6) Each
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009
2. Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study
3. Boehringer Ingelheim Initiates NEwArT Study Comparing Viramune(R) (nevirapine) to a Ritonavir-Boosted Atazanavir-based Regimen in Treatment-Naive HIV Patients
4. Ferring Pharmaceuticals Unveils Six-Month Efficacy Data for EUFLEXXA(R) for the Treatment of Osteoarthritis Knee Pain
5. OmegaGenesis Unveils Novel Nanotechnology Platform With Broad Biomedical Applications
6. Schering-Plough Unveils Top-Line Study Results for SAPHRIS(TM) (asenapine) Demonstrating Efficacy in Long-Term Schizophrenia Relapse Prevention
7. NeoVista Unveils 18-month Data on Novel Wet AMD Therapy at Retina Society Meeting
8. Oregon Tourism Commission Unveils New Online Customer Service Training Program
9. AFRESA(R) Phase 3 Pulmonary Function Safety Data in Patients with Diabetes Presented at ADA
10. Large, Long-Term Study Shows Avandia Has No Increased Overall Cardiovascular Risk Compared to Other Commonly Used Diabetes Medicines
11. Arena Pharmaceuticals Announces the Presentation of Lorcaserin Phase 3 BLOOM Data at the American Diabetes Associations 69th Scientific Sessions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... 23, 2014 Dans ... santé, le ferroviaire ou encore l,énergie, les ... progressivement accès à leurs données. Ces données ... installés au cœur des voitures, trains, avions, ... de milliards le nombre de machines connectées ...
(Date:9/23/2014)... , Sept. 23, 2014  Decision Resources ... reimbursement (P&R) decision criteria and payer requirements ... insights into each country, allow pharma to ... markets.  Global market access is extremely complex, ... access requirements and challenges—and a vast variety ...
(Date:9/23/2014)... ORLANDO, Fla. and DUBLIN ... Inc. (OTC-BB: TNIB) ("we" or the "Company"), a ... innovative therapies for autoimmune diseases in emerging nations, ... has approved our common stock for DTC,s Deposit ... Fast Automated Securities Transfer Service ("FAST") transfer agent ...
Breaking Medicine Technology:Altran transforme le big data du monde industriel en nouveau business 2Similarities In Key Global Markets Allow Pharma To Leverage Payer Value Messaging In Multiple Countries Through "Country Archetypes" Approach 2Similarities In Key Global Markets Allow Pharma To Leverage Payer Value Messaging In Multiple Countries Through "Country Archetypes" Approach 3Similarities In Key Global Markets Allow Pharma To Leverage Payer Value Messaging In Multiple Countries Through "Country Archetypes" Approach 4TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 2TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 3TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 4
... , WASHINGTON, Jan. 11 ... Baseball star Aaron Boone is featured in January on , Sharing ... that tells the compelling and inspirational stories of real patients. , Sharing ... is sponsored by the Pharmaceutical Research and Manufacturers of America ...
... , , SAN JOSE, Calif., Jan. ... and control solutions for life sciences process applications, announced ... TruFluor sensors for dissolved oxygen or pH and process ... family is optimized for accuracy, lifetime, and ease of ...
Cached Medicine Technology:Major League Baseball Star Aaron Boone on 'Sharing Miracles' 2Major League Baseball Star Aaron Boone on 'Sharing Miracles' 3Single-Use Sensor Product Family Enters High Volume Production 2
(Date:9/23/2014)... Dennis Thompson HealthDay Reporter ... Coupled with worldwide marches demanding action on climate change, ... weather patterns in the United States may soon exacerbate ... and other heat-related illnesses are expected to increase as ... author Dr. Jonathan Patz, director of the Global Health ...
(Date:9/23/2014)... at Cincinnati Children,s Hospital Medical Center have published ... (EG). The study, published in The Journal ... EG is a systemic disorder that has high ... tract, involves a series of allergy-associated-immune mechanisms and ... distinct from that of a related disorder, eosinophilic ...
(Date:9/23/2014)... a potential source of student diversity for medical ... however, there are significant challenges to enhancing the ... medical schools. The authors recommend that medical school ... be more inclusive of community college students. , ... Francisco and San Jose City College found that, ...
(Date:9/23/2014)... shows that adolescents who suffer from sleep disturbance or ... academically compared to those who enjoy a good night,s ... journal Sleep Medicine . , In a new ... and 19 from Uppsala County, researchers from Uppsala University ... sleep duration (less than 7 hours per day) increased ...
(Date:9/23/2014)... PA (PRWEB) September 23, 2014 If ... ongoing dialysis, dressing for the treatment may be a ... a type of garment that is designed to improve ... patients to receive dialysis without having to remove, tear ... while insuring privacy and preserving their dignity. At the ...
Breaking Medicine News(10 mins):Health News:Health Woes to Worsen Due to Climate Change, Study Warns 2Health News:Health Woes to Worsen Due to Climate Change, Study Warns 3Health News:Advancing the understanding of an understudied food allergy disorder 2Health News:Advancing the understanding of an understudied food allergy disorder 3Health News:Medical students who attended community college likelier to serve poor communities 2Health News:Apparel for Dialysis Patients Invented by InventHelp Client (CBA-2492) 2
... a quarter million deaths in the United States annually, ... as prescribed . A Mayo Clinic research team has ... medications. The tool is clearly effective and preferred by ... in the May 28 issue of the Archives of ...
... increase levels of high-density lipoprotein, or 'good,' ... issue of Archives of Internal Medicine. ... is an independent risk factor for cardiovascular disease, ... background information in the article. There is strong ...
... better predict the likelihood of full or partial recovery ... according to a study published in the June issue ... that the possibility and extent of neurological recovery after ... by rigorous assessment of MR images," said co-author Michael ...
... Asia - including India's - met European Union members in ... crises. ,The two-day Asia-Europe Meeting (ASEM) of 43 ... seeking deep cuts in world carbon-dioxide emissions and Asian governments ... held every two years. India, Pakistan and Mongolia are attending ...
... multidetector computed tomography (MDCT) can aid forensics teams in ... study published in the June issue of Radiology . ... demonstrating airway froth and sediment that are indicative of ... be used either to facilitate or reduce the need ...
... genes may actually contribute to learning the supposed "tonal languages", ... of Edinburgh University, UK, have exposed the first obvious connection ... in tonal languages can fundamentally alter the meaning of words, ... are so tough to learn for speakers of non-tonal languages ...
Cached Medicine News:Health News:Simple Tool Developed for Diabetics to Improve Compliance With Medications 2Health News:Simple Tool Developed for Diabetics to Improve Compliance With Medications 3Health News:Regular Exercise may Slightly Increase HDL Levels 2Health News:Recovery from Spinal Cord Injury can Be Predicted Using MRI 2Health News:EU Pushes Asian Nations on Climate Change Goals 2Health News:Death Due to Drowning can Be Identified With the Aid of 'Virtual Autopsy' 2Health News:Genes may Have a Role in Learning "tonal Languages" 2
... When your eyes feel dry, scratchy, or ... going to last. REFRESH PLUS® lubricant eye ... symptoms could be what youre looking for. ... the moisture eyes crave with a special ...
Due to its thick formula, REFRESH CELLUVISC Lubricant Eye Drops is ideal for persistent dry eye conditions. REFRESH CELLUVISC provides lasting relief and protection for dry, scratchy eyes....
...
ALPHAGAN® (brimonidine tartrate ophthalmic solution) 0.2% is indicated for lowering IOP in patients with open-angle galucoma or ocular hypertension....
Medicine Products: